BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
48 hedge funds and large institutions have $11M invested in BRAINSTORM CELL THERAPUTC in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 17 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $15.3M → $11M (-$4.3M)
65% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 17
Holders
48
Holding in Top 10
–
Calls
$2.45M
Puts
$308K
Top Buyers
| 1 | +$82K | |
| 2 | +$57K | |
| 3 | +$47K | |
| 4 |
Jane Street
New York
|
+$33K |
| 5 |
SCFS
S.C. Financial Services
Scottsdale,
Arizona
|
+$28K |
Top Sellers
| 1 | -$217K | |
| 2 | -$163K | |
| 3 | -$140K | |
| 4 |
Millennium Management
New York
|
-$86.4K |
| 5 |
WCG
Weaver Consulting Group
Huntington Beach,
California
|
-$70K |